Evotec SE (EVO) Operating Expenses (2009 - 2025)
Evotec SE (EVO) reported Operating Expenses of -$51683.5 for Q4 2025, up 3.07% on a YoY basis from -$50142.0 in Q4 2024, and down 219.0% sequentially from -$16201.9 in Q3 2025.
Evotec SE (EVO) Operating Expenses (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Operating Expenses data on file, last reported at -$51683.5 in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 3.07% year-over-year to -$51683.5; the trailing twelve-month figure through Mar 2026 stood at -$67885.5 (down 7.15% YoY), and the FY2025 full-year result was -$204871.7, down 1.87% from the prior year.
- Operating Expenses declined to -$51683.5 in Q4 2025, from -$16201.9 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $21603.4 in Q3 2021 to a low of -$137163.0 in Q4 2023.
- A 5-year average of -$44754.3 and a median of -$35427.7 in 2022 frame the typical range for Operating Expenses.
- Peak annual rise in Operating Expenses reached 61.12% in 2024, while the deepest fall reached 76689.95% in 2024.
- Tracing EVO's Operating Expenses over 5 years: stood at -$120626.0 in 2021, then increased by 7.08% to -$112082.3 in 2022, then dropped by 22.38% to -$137163.0 in 2023, then jumped by 61.12% to -$53322.9 in 2024, then grew by 3.07% to -$51683.5 in 2025.
- Business Quant data shows EVO's Operating Expenses at -$51683.5 in Q4 2025, -$16201.9 in Q3 2025, and -$53322.9 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51,683.53 |
| Sep 30, 2025 | -16,201.93 |
| Dec 31, 2024 | -53,322.91 |
| Sep 30, 2024 | -10,031.14 |
| Dec 31, 2023 | -137,162.97 |
| Sep 30, 2023 | -13.06 |
| Jun 30, 2023 | -69,794.61 |
| Dec 31, 2022 | -112,082.34 |
| Sep 30, 2022 | 18,972.70 |
| Jun 30, 2022 | -58,213.28 |
| Mar 31, 2022 | -35,427.71 |
| Dec 31, 2021 | -120,626.02 |
| Sep 30, 2021 | 21,603.36 |
| Jun 30, 2021 | -21,766.00 |
| Mar 31, 2021 | -25,564.97 |
| Dec 31, 2020 | -92,090.08 |
| Sep 30, 2020 | 20,532.46 |
| Dec 31, 2019 | 138.20 Mn |
| Sep 30, 2010 | 6,656.51 |
| Jun 30, 2010 | 7,278.05 |